Skip to main content
. 2021 Jan 15;10(3):1034–1042. doi: 10.1002/cam4.3691

FIGURE 1.

FIGURE 1

Flow chart depicting patient selection for the study. EDM, exonuclease domain mutation; IHC, immunohistochemistry; MMR, mismatch repair; MS‐MLPA, methylation‐specific multiplex ligation‐dependent probe amplification; NSMP, no specific molecular profile; POLE, polymerase ϵ; TMA, tissue microarray